Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verisk Analytics
VRSK
|
+$438M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$309M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$274M |
| 4 |
PepsiCo
PEP
|
+$229M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$752M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$448M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.02% |
| 2 | Healthcare | 5.4% |
| 3 | Consumer Discretionary | 4.87% |
| 4 | Financials | 4.64% |
| 5 | Industrials | 3.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
Sprout Social
SPT
$509M
| $308K | ﹤0.01% |
6,174
-20,389
| -77% | -$1.02M |
|
3277
Warby Parker
WRBY
$3.19B
| $306K | ﹤0.01% |
23,273
-3,864
| -14% | -$50.2K |
|
|
FINV
3278
FinVolution Group
FINV
$1.15B
| $306K | ﹤0.01% |
61,498
-1,025
| -2% | -$5.36K |
|
3279
Bristow Group
VTOL
$1.32B
| $306K | ﹤0.01% |
10,859
-6,459
| -37% | -$187K |
|
|
AIV
3280
Aimco
AIV
$383M
| $306K | ﹤0.01% |
44,960
-37,013
| -45% | -$295K |
|
3281
Simulations Plus
SLP
$370M
| $306K | ﹤0.01% |
7,331
-6,403
| -47% | -$290K |
|
3282
WPP
WPP
$4.41B
| $304K | ﹤0.01% |
6,827
-1,148
| -14% | -$57.3K |
|
3283
Corebridge Financial
CRBG
$14.4B
| $304K | ﹤0.01% |
15,388
+4,506
| +41% | +$83.8K |
|
3284
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.23B
| $302K | ﹤0.01% |
7,808
-305
| -4% | -$12.1K |
|
3285
B&G Foods
BGS
$293M
| $302K | ﹤0.01% |
30,551
-22,198
| -42% | -$275K |
|
3286
Relmada Therapeutics
RLMD
$562M
| $299K | ﹤0.01% |
99,523
-19,795
| -17% | -$58.8K |
|
3287
AngloGold Ashanti
AU
$41.6B
| $297K | ﹤0.01% |
18,793
-129,393
| -87% | -$2.44M |
|
3288
CALL
Seres Therapeutics
MCRB
$46.3M
| $297K | ﹤0.01% |
6,235
-6,925
| -53% | -$528K |
|
|
3289
PUT
Seres Therapeutics
MCRB
$46.3M
| $297K | ﹤0.01% |
6,235
-425
| -6% | -$32.4K |
|
3290
AdaptHealth
AHCO
$1.45B
| $296K | ﹤0.01% |
32,578
-21,309
| -40% | -$255K |
|
|
CMPS
3291
CALL
Compass Pathways
CMPS
$1.56B
| $296K | ﹤0.01% |
40,000
| – | – |
|
|
AGR
3292
DELISTED
Avangrid, Inc.
AGR
| $295K | ﹤0.01% |
9,791
+334
| +4% | +$11.8K |
|
|
ASAI
3293
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $295K | ﹤0.01% |
24,219
+7,172
| +42% | +$94.1K |
|
3294
iShares Morningstar Small-Cap Value ETF
ISCV
$695M
| $294K | ﹤0.01% |
5,683
+1,535
| +37% | +$84.1K |
|
3295
First Trust Smith Opportunistic Fixed Income ETF
FIXD
$3.23B
| $293K | ﹤0.01% |
6,960
+8
| +0.1% | +$347 |
|
|
LAC
3296
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $292K | ﹤0.01% |
17,119
+6,941
| +68% | +$131K |
|
3297
MakeMyTrip
MMYT
$5.37B
| $290K | ﹤0.01% |
7,167
-1,979
| -22% | -$68.6K |
|
3298
PRA Group
PRAA
$662M
| $290K | ﹤0.01% |
15,095
-16,587
| -52% | -$349K |
|
3299
Adtran
ADTN
$682M
| $290K | ﹤0.01% |
35,232
-28,053
| -44% | -$249K |
|
|
HZNP
3300
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $289K | ﹤0.01% |
2,500
| – | – |
|
Similar funds
Citigroup's Q3 2023 Portfolio in Review
As of Q3 2023, Citigroup held 5,915 positions worth $134B, down 12% from $153B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citigroup withdrew a net $13.8B in Q3 2023, closing 265 positions and reducing 3,110 holdings. Its most notable exit was Magellan Midstream Partners, L.P., an estimated $121M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Opera Ltd worth $31.8M.
- Citigroup's largest Q3 2023 buy was Opera Ltd: 2,825,474 shares worth $31.8M.
- Citigroup added most to Verisk Analytics in Q3 2023, an estimated $438M increase.
- Citigroup's biggest Q3 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citigroup fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $121M.
- Citigroup's ten largest holdings make up 30% of its $134B portfolio in Q3 2023.
- Citigroup opened 337 new positions and closed 265 in Q3 2023.
- Citigroup's portfolio value fell 12% quarter-over-quarter to $134B.
Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.